Daniel Guinart, MD

Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...

Antipsychotic polypharmacy in schizophrenia is common, but is it supported by evidence? And why is there an apparent disconnect between efficacy and effectiveness? This ASCP Corner article considers those...